A Two-Stage Data Mining and Randomized Controlled Trial Approach to Evaluate the Gouteng Xiakucao Formula for Essential Hypertension Comorbid with Anxiety Disorder of Liver-Yang Hyperactivity Pattern
X-Disciplinarity · 27.05.2026 · 2 (3) · 2
DOI: 10.63174/xdi.sznf4529 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift X-Disciplinarity, online erschienen am 27.05.2026. Verfasst von Xinyu Wang und 2 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Essential hypertension (EH) comorbid with anxiety disorder lacks optimal pharmacological options, and Traditional Chinese Medicine (TCM) formula construction has historically relied on classical theory rather than systematic data-driven evaluation. We addressed this gap through a two-stage workflow. Stage 1 was a retrospective data mining analysis of 114 EH–anxiety patients combining association rule, factor, and hierarchical cluster analysis of TCM prescriptions; it identified Liver-Yang Hyperactivity (LYH) as the predominant syndrome (52.63%) and Gouteng–Xiakucao as the highest-confidence herb pair (support 50.88%, confidence 94.83%), and anchored construction of the Gouteng Xiakucao Formula (GXF). Stage 2 randomized 128 patients with EH–anxiety comorbidity of LYH pattern 1:1 to valsartan plus GXF or valsartan plus oryzanol for 14 days. The GXF arm showed significantly greater post-treatment reductions than control in systolic blood pressure (134.03 ± 8.17 vs 137.18 ± 6.92 mmHg, P = 0.026), diastolic blood pressure (80.93 ± 3.88 vs 83.42 ± 4.31 mmHg, P = 0.001), Hamilton Anxiety Rating Scale score (11.63 ± 2.66 vs 12.76 ± 3.08, P = 0.036), Pittsburgh Sleep Quality Index (P = 0.015), and TCM syndrome score (P = 0.002); the SF-36 Physical Functioning, Social Functioning, and Mental Health subscales also improved more in the GXF arm, with no clinically meaningful adverse changes. This data-driven TCM formula derived from real-world prescription mining produced superior short-term outcomes compared with an oryzanol-based comparator in patients with EH–anxiety comorbidity of LYH pattern, illustrating a feasible paradigm for systematic TCM formula development and prospective validation.
Zitieren
APA
Wang, X., Su, X., & Wang, Y. (2026). A Two-Stage Data Mining and Randomized Controlled Trial Approach to Evaluate the Gouteng Xiakucao Formula for Essential Hypertension Comorbid with Anxiety Disorder of Liver-Yang Hyperactivity Pattern. X-Disciplinarity, 2(3), 2. https://doi.org/10.63174/xdi.sznf4529
Vancouver
Wang X, Su X, Wang Y. A Two-Stage Data Mining and Randomized Controlled Trial Approach to Evaluate the Gouteng Xiakucao Formula for Essential Hypertension Comorbid with Anxiety Disorder of Liver-Yang Hyperactivity Pattern. X-Disciplinarity. 2026;2(3):2. doi:10.63174/xdi.sznf4529
BibTeX
@article{Wang2026,
author = {Wang, Xinyu and Su, Xiangyu and Wang, Yu},
title = {A Two-Stage Data Mining and Randomized Controlled Trial Approach to Evaluate the Gouteng Xiakucao Formula for Essential Hypertension Comorbid with Anxiety Disorder of Liver-Yang Hyperactivity Pattern},
journal = {X-Disciplinarity},
year = {2026},
volume = {2},
number = {3},
pages = {2},
doi = {10.63174/xdi.sznf4529}
}
EUVIMED